Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


Insights into Chemoresistance of Prostate Cancer.

Zhang W, Meng Y, Liu N, Wen XF, Yang T.

Int J Biol Sci. 2015 Aug 1;11(10):1160-70. doi: 10.7150/ijbs.11439. eCollection 2015. Review.


Small Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer Center.

Ahmed S, Neufeld S, Kroczak TJ, Bashir B, Ahmed N, Czaykowski P, Aljada I, Koul R, Galloway K, Drachenberg DE.

Cureus. 2015 Aug 7;7(8):e296. doi: 10.7759/cureus.296. eCollection 2015 Aug.


Diagnosis of prostatic neuroendocrine carcinoma: Two cases report and literature review.

He HQ, Fan SF, Xu Q, Chen ZJ, Li Z.

World J Radiol. 2015 May 28;7(5):104-9. doi: 10.4329/wjr.v7.i5.104.


Distinct genetic alterations in small cell carcinoma from different anatomic sites.

Zheng X, Liu D, Fallon JT, Zhong M.

Exp Hematol Oncol. 2015 Jan 14;4:2. doi: 10.1186/2162-3619-4-2. eCollection 2015. Review.


Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis.

McPartlin A, Grimaldo C, Lyons J, Burke D, Mitra S, Choudhury A.

Clin Kidney J. 2014 Dec;7(6):593-4. doi: 10.1093/ckj/sfu097. Epub 2014 Sep 16.


Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?

Grigore AD, Ben-Jacob E, Farach-Carson MC.

Front Oncol. 2015 Mar 3;5:37. doi: 10.3389/fonc.2015.00037. eCollection 2015. Review.


Neuroendocrine differentiation of prostate cancer: a review.

Parimi V, Goyal R, Poropatich K, Yang XJ.

Am J Clin Exp Urol. 2014 Dec 9;2(4):273-85. eCollection 2014. Review.


Clinicopathological analysis on small cell carcinoma of the prostate in chinese patients.

Guo A, Wen S, Ma Y, Wei L, Liu A.

J Cancer. 2014 Nov 4;5(9):797-803. doi: 10.7150/jca.9388. eCollection 2014.


Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report.

Hingorani R, Young J, Alweis R.

J Community Hosp Intern Med Perspect. 2014 Nov 25;4(5):25176. doi: 10.3402/jchimp.v4.25176. eCollection 2014.


SOX2 expression in the developing, adult, as well as, diseased prostate.

Yu X, Cates JM, Morrissey C, You C, Grabowska MM, Zhang J, DeGraff DJ, Strand DW, Franco OE, Lin-Tsai O, Hayward SW, Matusik RJ.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):301-9. doi: 10.1038/pcan.2014.29. Epub 2014 Aug 5.


High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.

Zheng X, Zhuge J, Bezerra SM, Faraj SF, Munari E, Fallon JT 3rd, Yang XJ, Argani P, Netto GJ, Zhong M.

J Hematol Oncol. 2014 Jul 20;7:47. doi: 10.1186/s13045-014-0047-7.


Complete chemotherapeutic regression of a non-metastatic case of primary pure small cell carcinoma of the prostate.

Yahyazadeh SH, Abadpour B, Molanaei S, Jamali A.

Curr Urol. 2012 May;6(1):43-5. doi: 10.1159/000338869. Epub 2012 Apr 30.


Characterization of the genomic architecture and mutational spectrum of a small cell prostate carcinoma.

Scott AF, Mohr DW, Ling H, Scharpf RB, Zhang P, Liptak GS.

Genes (Basel). 2014 May 12;5(2):366-84. doi: 10.3390/genes5020366.


Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA.

Am J Surg Pathol. 2014 Jun;38(6):756-67. doi: 10.1097/PAS.0000000000000208.


Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J.

Asian J Androl. 2014 Jul-Aug;16(4):541-4. doi: 10.4103/1008-682X.123669. Review.


Small cell carcinoma of the prostate.

Nadal R, Schweizer M, Kryvenko ON, Epstein JI, Eisenberger MA.

Nat Rev Urol. 2014 Apr;11(4):213-9. doi: 10.1038/nrurol.2014.21. Epub 2014 Feb 18. Review.


Mouse models of prostate cancer: picking the best model for the question.

Grabowska MM, DeGraff DJ, Yu X, Jin RJ, Chen Z, Borowsky AD, Matusik RJ.

Cancer Metastasis Rev. 2014 Sep;33(2-3):377-97. doi: 10.1007/s10555-013-9487-8. Review.


The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Bitting RL, Schaeffer D, Somarelli JA, Garcia-Blanco MA, Armstrong AJ.

Cancer Metastasis Rev. 2014 Sep;33(2-3):441-68. doi: 10.1007/s10555-013-9483-z. Review.


Small cell carcinoma of the urinary bladder and prostate: Cytological analyses of four cases with emphasis on the usefulness of cytological examination.

Yoshida K, Ishida M, Kagotani A, Iwamoto N, Iwai M, Okabe H.

Oncol Lett. 2014 Feb;7(2):369-372. Epub 2013 Nov 29.


Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.

Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL.

Clin Cancer Res. 2014 Feb 15;20(4):890-903. doi: 10.1158/1078-0432.CCR-13-1982. Epub 2013 Dec 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk